Teradyne, Inc.

NASDAQ Global Select
Back to all articles
Bullish +65

Boston Trust Walden Corp Has $10.60 Million Stock Position in Teradyne ...

📉 Boston Trust Walden Corp lowered its Teradyne stake by 92.1% in Q1, selling 416,012 shares while retaining 35,741 shares worth $10.6 million.

📈 UMB Bank n.a., Stephens Inc. AR, Sapient Capital LLC, Truvestments Capital LLC, and IFP Advisors Inc. all increased their Teradyne positions in the fourth quarter.

💰 Teradyne reported Q1 revenue of $1.28 billion, representing an 87% year-over-year increase compared to the previous year's period.

📊 The company beat earnings estimates with $2.56 per share versus a consensus of $2.11, achieving a net margin of 22.55% and ROE of 31.79%.

💵 Teradyne paid a quarterly dividend of $0.13 per share on June 12th, raising the annualized yield to 0.52% from the previous quarter.

🚀 Citigroup raised its price target to $400 with a buy rating, while Cantor Fitzgerald lifted its objective to $550 with an overweight rating.

📈 Robert W. Baird increased its target to $446 and gave an outperform rating, alongside Evercore setting a $370 target price.

⭐ Zacks Research upgraded Teradyne from a hold to a strong-buy rating in a note dated May 12th.

👔 CEO Gregory Stephen Smith sold 4,000 shares for $1.69 million under a pre-arranged Rule 10b5-1 trading plan on June 15th.

🏢 VP Ryan Driscoll sold 680 shares for $256,768 on May 7th as part of a pre-arranged trading plan.

📉 Insiders collectively sold 14,941 shares worth $5.44 million over the last 90 days, though they still own 0.19% of the company.

🏭 Teradyne is a global supplier of automatic test equipment for semiconductors and wireless products headquartered in North Reading, Massachusetts.

Bullish Signals
  • Teradyne reported Q1 revenue of $1.28 billion, an 87% year-over-year increase that significantly exceeded the consensus estimate of $1.20 billion.
  • The company beat earnings per share expectations with a result of $2.56 compared to the analyst consensus of $2.11.
  • Teradyne achieved a robust net margin of 22.55% and a return on equity of 31.79% during the quarter.
  • Major investment banks including Citigroup, Cantor Fitzgerald, and Robert W. Baird have raised their price targets to between $400 and $550 following recent performance.
  • Zacks Research upgraded the stock from a hold to a strong-buy rating, reflecting improved analyst sentiment.
  • The company increased its quarterly dividend to $0.13 per share, raising the annualized yield to 0.52%.
Risk Factors
  • Boston Trust Walden Corp reduced its stake in Teradyne by 92.1% during the first quarter, indicating a significant exit by a major institutional holder.
  • Insiders sold a total of 14,941 shares worth $5.44 million over the last 90 days, including sales by the CEO and VP under pre-arranged trading plans.
Full Analysis
Boston Trust Walden Corp significantly reduced its stake in Teradyne, Inc. (NASDAQ:TER) by 92.1% during the first quarter, selling 416,012 shares to retain a position of 35,741 shares valued at approximately $10.6 million. While this major institutional holder exited most of its position, several smaller institutional investors and hedge funds, including UMB Bank n.a., Stephens Inc. AR, and Sapient Capital LLC, modestly increased their holdings in the fourth quarter. Teradyne reported strong financial performance for the quarter ended April 29th, with revenue reaching $1.28 billion, an 87% year-over-year increase that beat analyst consensus estimates of $1.20 billion. The company posted earnings per share of $2.56, surpassing the expected $2.11, and achieved a net margin of 22.55% with a return on equity of 31.79%. Analysts project full-year earnings of $7.2 per share. The stock has received widespread analyst support following the earnings beat, with major firms like Citigroup, Cantor Fitzgerald, and Robert W. Baird raising their price targets to between $370 and $550 while maintaining buy or overweight ratings. Zacks Research upgraded the stock to a strong-buy rating, contributing to a consensus target price of $382.87 and a moderate buy consensus from MarketBeat.